Terry Segal is a consultant in general paediatrics and adolescent medicine, with an interest in paediatric and adolescent endocrinology. She is the clinical lead for adolescent medicine.
She trained in Bristol University, and after returning to London, she undertook postgraduate paediatric, adolescent and endocrinology training at Whittington, Guy's, Great Ormond Street, Barnet, and UCH/Middlesex hospitals.
She is particularly interested in working with overweight and underweight children and young people, adolescent problems such as chronic fatigue syndrome/ME, and those with chronic pain and emotional difficulties.
- Paediatric endocrinology (growth and puberty)
- Chronic fatigue syndrome
- ObesityAnorexia nervosa (medical aspects)Chronic medically unexplained symptoms
Segal TY & Viner RM. Adolescent Medicine. 3rd edition of Illustrated Textbook of paediatrics. Lissauer T. ed ( 2006)
Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. TY Segal, A Mehta, A Anazodo, PC Hindmarsh, MT Dattani - Journal of Clinical Endocrinology and Metabolism, 2009: 2009: 94(3): 780-785
Severe Insulin Resistance secondary to Insulin Antibodies: Successful treatment with the immunosuppressant Mycophenolate Mofetil (MMF); Segal T1, Webb EA1, Viner R1, Pusey C2, Wild G3, Allgrove . Paediatric Diabetes 2007; 9(3): 250-254
Fionnuala A Stuart, Terry Y Segal, and Simon Keady ; Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child. 2005 May;90(5):500-6.Review
Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P; Prevalence of the Insulin resistance syndrome (IRS) in obesity. Arch Dis Child. 2005 Jan; 90(1):10-4.
Segal TY, Viner RM, Hindmarsh PC. Disturbed adrenal function in adolescents with chronic fatigue syndrome. J Pediatr Endocrinol Metab. 2005 Mar;18(3):295-301.and Arch Dis Child 2003; 88(SupplI): A8.)
Reid CJD, Segal T. Pulmonary thrombo-embolism in nephritic syndrome treated with tissue plasminogen activator. T.Eur.J Pediatr.1997 Aug; 156(8):647-9